Menu

Markets

Research

News

Learn
Paper trading
AI Chat
WatchlistsPortfoliosAlerts
Sign in

APDN

Applied DNA Sciences, Inc.

Healthcare

Set alert

Price alert · APDN

All alert types
5.62 0.00 0.00%
As of Oct 6, 2025
4.61 Day range 5.80

52-week range unavailable

YTD
-44.90%
1 year
-69.59%
Open
4.70
Prev close
5.62
Mkt cap
9.37M
Vol
2.65M
Avg vol
0
EPS
0.00
P/E
0.00
Div yield
0.00%
More statistics
Low
4.61
High
5.80
Forward P/E
-0.17
Beta
0.45
Short ratio
0.47
Inst. own
25.01%
Dividend
0.00
Ex-div date
Earnings
Feb 13, 2025
50-d avg
0.2148
200-d avg
2.09
1y target
0.00

5D chart

Chart tools
Interval
1m5m15m30m

Chart is warming up

The five-day price history for APDN has not been loaded yet. Try again in a moment.

Financial health

Altman Z-Score

-34.16 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

3 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -0.0×
FY 2016: -6.0×FY 2017: -5.9×FY 2018: -3.6×FY 2019: -0.9×FY 2020: -2.3×FY 2021: -2.6×FY 2022: -1.2×FY 2023: -1.6×FY 2024: -0.4×FY 2025: -0.0×
FY 2016 5y median -1.2× FY 2025
P/S 1.1×
FY 2016: 17.3×FY 2017: 15.9×FY 2018: 10.7×FY 2019: 1.5×FY 2020: 15.7×FY 2021: 4.1×FY 2022: 0.6×FY 2023: 1.2×FY 2024: 0.8×FY 2025: 1.1×
FY 2016 5y median 1.1× FY 2025
P/B 1.2×
FY 2016: 7.0×FY 2017: 11.0×FY 2018: 55.1×FY 2019: -9.8×FY 2020: 5.3×FY 2021: 3.4×FY 2022: 0.8×FY 2023: 3.2×FY 2024: 0.3×FY 2025: 1.2×
FY 2016 5y median 1.2× FY 2025
P/FCF -0.2×
FY 2016: -6.8×FY 2017: -9.9×FY 2018: -5.8×FY 2019: -1.2×FY 2020: -2.5×FY 2021: -2.3×FY 2022: -1.1×FY 2023: -2.5×FY 2024: -0.2×FY 2025: -0.2×
FY 2016 5y median -1.1× FY 2025
EV/EBITDA 2.4×
FY 2016: -5.9×FY 2017: -6.1×FY 2018: -3.7×FY 2019: -1.1×FY 2020: -2.0×FY 2021: -2.6×FY 2022: 0.4×FY 2023: -1.0×FY 2024: 0.2×FY 2025: 2.4×
FY 2016 5y median 0.2× FY 2025
EV/Sales 0.4×
FY 2016: 16.2×FY 2017: 15.3×FY 2018: 10.6×FY 2019: 1.7×FY 2020: 12.9×FY 2021: 3.4×FY 2022: -0.3×FY 2023: 0.7×FY 2024: -0.9×FY 2025: 0.4×
FY 2016 5y median 0.4× FY 2025
FCF Yield -523.9%
FY 2016: -14.8%FY 2017: -10.1%FY 2018: -17.3%FY 2019: -84.1%FY 2020: -40.3%FY 2021: -42.7%FY 2022: -93.4%FY 2023: -39.8%FY 2024: -547.9%FY 2025: -523.9%
FY 2016 5y median -93.4% FY 2025

Profitability

Gross Margin 39.3%
FY 2016: 82.2%FY 2017: 77.3%FY 2018: 69.1%FY 2019: 83.7%FY 2020: 62.7%FY 2021: 54.6%FY 2022: 27.8%FY 2023: 41.4%FY 2024: 29.6%FY 2025: 39.3%
FY 2016 5y median 39.3% FY 2025
Operating Margin -750.9%
FY 2016: -291.4%FY 2017: -269.8%FY 2018: -298.4%FY 2019: -169.3%FY 2020: -649.0%FY 2021: -136.2%FY 2022: -76.9%FY 2023: -81.9%FY 2024: -408.7%FY 2025: -750.9%
FY 2016 5y median -136.2% FY 2025
Net Margin -3251.7%
FY 2016: -290.8%FY 2017: -270.6%FY 2018: -299.6%FY 2019: -160.2%FY 2020: -660.9%FY 2021: -177.6%FY 2022: -46.1%FY 2023: -74.4%FY 2024: -203.8%FY 2025: -3251.7%
FY 2016 5y median -177.6% FY 2025
ROE -3578.7%
FY 2016: -117.5%FY 2017: -187.5%FY 2018: -1549.8%FY 2019: 1025.9%FY 2020: -223.2%FY 2021: -144.2%FY 2022: -64.9%FY 2023: -200.9%FY 2024: -76.5%FY 2025: -3578.7%
FY 2016 5y median -144.2% FY 2025
ROIC -740.6%
FY 2016: -106.1%FY 2017: -186.9%FY 2018: -414.2%FY 2019: -691.9%FY 2020: -140.8%FY 2021: -110.3%FY 2022: -77.3%FY 2023: -96.9%FY 2024: -128.2%FY 2025: -740.6%
FY 2016 5y median -110.3% FY 2025
ROA -1565.9%
FY 2016: -78.2%FY 2017: -157.7%FY 2018: -207.6%FY 2019: -242.2%FY 2020: -112.6%FY 2021: -111.2%FY 2022: -37.6%FY 2023: -72.9%FY 2024: -54.7%FY 2025: -1565.9%
FY 2016 5y median -72.9% FY 2025

Growth (YoY)

Revenue -37.7%
FY 2016: -53.5%FY 2017: 13.5%FY 2018: -17.8%FY 2019: 38.1%FY 2020: -64.2%FY 2021: 367.4%FY 2022: 101.3%FY 2023: -26.4%FY 2024: -74.3%FY 2025: -37.7%
FY 2016 FY 2025
Operating Income -14.4%
FY 2016: -55.3%FY 2017: -5.1%FY 2018: 9.2%FY 2019: 21.7%FY 2020: -37.4%FY 2021: 1.9%FY 2022: -13.6%FY 2023: 21.6%FY 2024: -28.0%FY 2025: -14.4%
FY 2016 FY 2025
EPS (diluted) 90.2%
FY 2016: 19.0%FY 2017: 3.9%FY 2018: 19.1%FY 2019: 38.9%FY 2020: 65.7%FY 2021: 37.9%FY 2022: 54.8%FY 2023: 18.6%FY 2024: 88.0%FY 2025: 90.2%
FY 2016 FY 2025
Free Cash Flow 11.1%
FY 2016: -40.5%FY 2017: 28.6%FY 2018: 5.8%FY 2019: 3.5%FY 2020: -76.2%FY 2021: -30.6%FY 2022: 40.6%FY 2023: 33.5%FY 2024: -124.3%FY 2025: 11.1%
FY 2016 FY 2025

Financial Health

Current Ratio 0.9×
FY 2016: 2.8×FY 2017: 4.8×FY 2018: 1.4×FY 2019: 1.0×FY 2020: 2.1×FY 2021: 3.5×FY 2022: 4.8×FY 2023: 2.9×FY 2024: 3.4×FY 2025: 0.9×
FY 2016 5y median 3.4× FY 2025
Quick Ratio 0.9×
FY 2016: 2.7×FY 2017: 4.6×FY 2018: 1.3×FY 2019: 0.9×FY 2020: 2.0×FY 2021: 3.0×FY 2022: 4.6×FY 2023: 2.7×FY 2024: 3.2×FY 2025: 0.9×
FY 2016 5y median 3.0× FY 2025
Debt / Equity 0.1×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: 2.1×FY 2019: -1.8×FY 2020: 0.4×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.2×FY 2024: 0.1×FY 2025: 0.1×
FY 2016 5y median 0.1× FY 2025
Net Debt / EBITDA -3.8×
FY 2016: 0.4×FY 2017: 0.2×FY 2018: 0.0×FY 2019: -0.1×FY 2020: 0.4×FY 2021: 0.6×FY 2022: 1.2×FY 2023: 0.6×FY 2024: 0.4×FY 2025: -3.8×
FY 2016 5y median 0.6× FY 2025
Interest Coverage 0.0×
FY 2016: 0.0×FY 2017: 0.0×FY 2018: -1211×FY 2019: -56.2×FY 2020: -108×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×FY 2025: 0.0×
FY 2016 5y median 0.0× FY 2025

Dividends

Dividend Yield 2266.6%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 1.1%FY 2023: 0.0%FY 2024: 9.0%FY 2025: 2266.6%
FY 2016 5y median 1.1% FY 2025
Payout Ratio -78.2%
FY 2016: 0.0%FY 2017: 0.0%FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -1.3%FY 2023: 0.0%FY 2024: -3.3%FY 2025: -78.2%
FY 2016 5y median -1.3% FY 2025

Annual · latest fiscal year ends 2025-09-30